Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06899750 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Oct 1, 2026 → Dec 31, 2026
See other at-risk trials from Rush University Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Oct 1, 2026 to Dec 31, 2026
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description revised
  2. Primary completion date: Mar 1, 2026 to Oct 1, 2026v3
  3. Primary completion date: Sep 1, 2025 to Mar 1, 2026
    • Study completion date: Mar 1, 2026 to Oct 1, 2026
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to compare a multidisciplinary clinical hypertension and social needs intervention to enhanced standard of care for hypertension management in primary care clinics with regards to hypertension control outcomes.
Trial Details
NCT Number NCT06899750
Lead Sponsor Rush University Medical Center
Collaborators: Novartis Pharmaceuticals
Conditions
(from sponsor)		 Hypertension
Related terms Hypertension
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov